abnormal cytokinesis cells deficient breast cancer susceptibility protein brca2 
germ-line mutations inactivating brca2 predispose cancer brca2-deficient cells exhibit alterations chromosome number aneuploidy well structurally aberrant chromosomes show brca2 deficiency impairs completion cell division cytokinesis brca2 inactivation murine embryo fibroblasts mefs hela cells targeted gene disruption rna interference delays prevents cell cleavage impeded cell separation accompanied abnormalities myosin ii organization late stages cytokinesis brca2 may role regulating events localizes cytokinetic midbody findings thus link cytokinetic abnormalities hereditary cancer syndrome characterized chromosomal instability may help explain brca2-deficient tumors frequently aneuploid 
